Insys Therapeutics Inc. appointed Vaseem Mahboob as a new independent member of its board.
Mahboob is the current CFO of Endologix Inc.
Insys Therapeutics appoints director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Insys Therapeutics Inc. appointed Vaseem Mahboob as a new independent member of its board.
Mahboob is the current CFO of Endologix Inc.